| scholarly article | Q13442814 |
| P50 | author | Janusz Rak | Q67256958 |
| Daniel Kirchhofer | Q88125023 | ||
| P2093 | author name string | Alisa S Wolberg | |
| Nigel Mackman | |||
| Nigel S Key | |||
| Julie C Williams | |||
| Jen Jen Yeh | |||
| Rafal Pawlinski | |||
| Maria M Aleman | |||
| Frank C Church | |||
| Jessica C Cardenas | |||
| Vladimir Y Bogdanov | |||
| Jian-Guo Wang | |||
| Pichika Chantrathammachart | |||
| Ronald R Bach | |||
| Julia E Geddings | |||
| P2860 | cites work | Prediction of venous thromboembolism in cancer patients. | Q51662626 |
| Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. | Q52826734 | ||
| Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. | Q64930704 | ||
| Tumor shedding and coagulation | Q70662680 | ||
| Tissue factor expression correlates with histological grade in human pancreatic cancer | Q71991852 | ||
| Immunologic quantitation of tissue factors | Q80031586 | ||
| Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer | Q80341297 | ||
| Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study | Q81683698 | ||
| A monoclonal antibody that inhibits mouse tissue factor function | Q81712040 | ||
| Microparticle-associated tissue factor activity in cancer patients with and without thrombosis | Q84009686 | ||
| Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation | Q27860759 | ||
| Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein | Q28185844 | ||
| Missing value estimation methods for DNA microarrays | Q28200763 | ||
| The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states | Q28396048 | ||
| Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation | Q33379387 | ||
| Determination of plasma tissue factor antigen and its clinical significance | Q33491061 | ||
| Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice | Q33728358 | ||
| Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer | Q33765406 | ||
| Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation | Q33867014 | ||
| Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells | Q33945484 | ||
| Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules | Q34408529 | ||
| Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis | Q34635642 | ||
| von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models | Q34666946 | ||
| Overexpression of the cell cycle inhibitor p16INK4a promotes a prothrombotic phenotype following vascular injury in mice | Q34915674 | ||
| Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner | Q35182740 | ||
| Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. | Q35738647 | ||
| Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. | Q35894194 | ||
| Development and validation of a predictive model for chemotherapy-associated thrombosis | Q36657982 | ||
| Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. | Q37331535 | ||
| Assessing risk of venous thromboembolism in the patient with cancer. | Q37393394 | ||
| Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. | Q37438142 | ||
| Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor, phosphatidylserine and phosphatidylethanolamine | Q39469405 | ||
| Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7. | Q39473936 | ||
| Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model | Q40049073 | ||
| Microparticle-associated tissue factor activity: a link between cancer and thrombosis? | Q40260694 | ||
| Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis | Q40502054 | ||
| Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism | Q40824665 | ||
| Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. | Q44654420 | ||
| An inhibitory monoclonal antibody against human tissue factor | Q48224968 | ||
| Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study | Q48661559 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombosis | Q261327 |
| pancreatic cancer | Q212961 | ||
| xenograft | Q64148587 | ||
| P304 | page(s) | 5543-5552 | |
| P577 | publication date | 2012-04-30 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer | |
| P478 | volume | 119 |
| Q26786677 | "Soluble Tissue Factor" in the 21st Century: Definitions, Biochemistry, and Pathophysiological Role in Thrombus Formation |
| Q26998742 | Activation of blood coagulation in cancer: implications for tumour progression |
| Q39141403 | Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma. |
| Q37295308 | Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma. |
| Q54117069 | Arterial Thrombosis in Patients with Cancer. |
| Q26774967 | Assessment of Venous Thrombosis in Animal Models |
| Q35896126 | Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma |
| Q92853263 | Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis |
| Q91979024 | Biomarkers of Cancer-Associated Thromboembolism |
| Q44264785 | Cancer and Thrombotic Risk: The Platelet Paradigm |
| Q98183379 | Cancer animal models in thrombosis research |
| Q39250608 | Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor |
| Q38642557 | Cancer-associated pathways and biomarkers of venous thrombosis |
| Q26830846 | Clinical significance of procoagulant microparticles |
| Q47916707 | Coagulation and fibrinolysis in gastric cancer |
| Q92758073 | Down-regulation of tissue factor inhibits invasion and metastasis of non-small cell lung cancer |
| Q38262939 | Engineered nanoparticles: thrombotic events in cancer. |
| Q99631228 | Evaluation of different commercial antibodies for their ability to detect human and mouse tissue factor by western blotting |
| Q39075118 | Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro |
| Q64229256 | Expression of flTF and asTF splice variants in various cell strains and tissues |
| Q41548598 | Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer |
| Q39107240 | Extracellular vesicles and blood diseases |
| Q88426785 | Extracellular vesicles and their content in bioactive lipid mediators: more than a sack of microRNA |
| Q34625129 | Extracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumours |
| Q38379177 | Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day |
| Q38202336 | Extracellular vesicles: emerging targets for cancer therapy. |
| Q38851727 | Generation and characterization of a monoclonal antibody against canine tissue factor |
| Q47192469 | Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size |
| Q36783220 | Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus |
| Q89620002 | Leukobiopsy - A Possible New Liquid Biopsy Platform for Detecting Oncogenic Mutations |
| Q95601551 | MICROVASCULAR THROMBOSIS: EXPERIMENTAL AND CLINICAL IMPLICATIONS |
| Q97520716 | Mechanisms and biomarkers of cancer-associated thrombosis |
| Q35062288 | Micropallet arrays for the capture, isolation and culture of circulating tumor cells from whole blood of mice engrafted with primary human pancreatic adenocarcinoma |
| Q39050585 | Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation? |
| Q46301727 | Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation |
| Q38805409 | Microparticles and cancer thrombosis in animal models. |
| Q26783691 | Microparticles as Biomarkers of Blood Coagulation in Cancer |
| Q50148338 | Mouse models of cancer-associated thrombosis |
| Q39119140 | Much More than Trousseau Syndrome. The Broad Spectrum of the Pancreatic Paraneoplastic Syndromes |
| Q91709974 | Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumors |
| Q47938011 | New findings on venous thrombogenesis |
| Q55652396 | New players in haemostasis and thrombosis. |
| Q92129780 | Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis |
| Q92468574 | Novel Role for the AnxA1-Fpr2/ALX Signaling Axis as a Key Regulator of Platelet Function to Promote Resolution of Inflammation |
| Q52726017 | Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis. |
| Q41820280 | Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles. |
| Q50990931 | Prognostic value of the D-dimer test in oesophageal cancer during the perioperative period. |
| Q38117725 | Revisited role of microparticles in arterial and venous thrombosis. |
| Q38543812 | Role of exosomes and microvesicles in hypoxia-associated tumour development and cardiovascular disease. |
| Q37157888 | Routine Hemostasis and Hemogram Parameters: Valuable Assessments for Coagulation Disorder and Chemotherapy in Cancer Patients |
| Q38202537 | Small but mighty: microparticles as mediators of tumor progression |
| Q42720838 | Strengths and weaknesses of a new mouse model of thrombosis induced by inferior vena cava stenosis: communication from the SSC of the ISTH. |
| Q39154286 | Supportive care in pancreatic ductal adenocarcinoma. |
| Q86107932 | Systemic and flap inflammatory response associates with thrombosis in flap venous crisis |
| Q38805371 | Targeting clotting proteins in cancer therapy - progress and challenges |
| Q55443866 | The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma. |
| Q92058056 | The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues |
| Q93271477 | The role of coagulation and platelets in colon cancer-associated thrombosis |
| Q61814938 | Thrombin Generation and Cancer: Contributors and Consequences |
| Q35832620 | Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice |
| Q90702701 | Tissue factor procoagulant activity in the tumor cell lines and plasma of dogs with various malignant tumors |
| Q50064062 | Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer |
| Q36470049 | Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice. |
| Q33795243 | Trousseau's Syndrome Caused by Intrahepatic Cholangiocarcinoma: An Autopsy Case Report and Literature Review |
| Q41124163 | Tumor-Derived Exosomes Induce the Formation of Neutrophil Extracellular Traps: Implications For The Establishment of Cancer-Associated Thrombosis. |
| Q37169096 | Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients |
| Q38214967 | Unconventional approaches to the prevention of cancer associated thrombosis |
| Q89217812 | Venous thrombosis |
| Q36636558 | Venous thrombosis and cancer: from mouse models to clinical trials. |
| Q93347982 | mTOR kinase inhibition reduces tissue factor expression and growth of pancreatic neuroendocrine tumors |
Search more.